Bang Chang Seok, Baik Gwang Ho
Department of Internal Medicine, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital, Chuncheon, Korea.
Clin Endosc. 2019 Jan;52(1):30-35. doi: 10.5946/ce.2018.158. Epub 2019 Jan 17.
Endoscopic submucosal dissection (ESD) is a standard treatment for patients with gastrointestinal neoplasms with a negligible risk of lymph node metastasis. ESD enables en bloc resection of gastrointestinal neoplasms and organ preservation, thereby, avoiding surgical treatment. Although small (<2 cm) intramucosal early gastric cancer with undifferentiated-type histology (EGC-UH) without ulceration is included in the expanded criteria for ESD, controversies remain due to different biology and characteristics compared to EGC with differentiated-type histology. The authors previously presented studies about the technical feasibility of ESD for these lesions using a meta-analysis and retrospective multicenter analysis. However, many pitfalls were identified in the interpretation of studies analyzing histologic discrepancy, mixed-type histology, criteria-based analysis of therapeutic outcomes, interpretation of curative resection, and long-term clinical outcomes. In this review, the authors discuss pitfalls in the interpretation of publications on ESD for EGC-UH.
内镜黏膜下剥离术(ESD)是治疗胃肠道肿瘤且淋巴结转移风险可忽略不计患者的标准治疗方法。ESD能够完整切除胃肠道肿瘤并保留器官,从而避免手术治疗。尽管无溃疡的小(<2 cm)黏膜内未分化型早期胃癌(EGC-UH)被纳入ESD的扩展标准,但与分化型组织学的早期胃癌相比,由于生物学特性和特征不同,仍存在争议。作者之前通过荟萃分析和回顾性多中心分析,发表了关于ESD治疗这些病变的技术可行性的研究。然而,在分析组织学差异、混合型组织学、基于标准的治疗结果分析、根治性切除的解读以及长期临床结果的研究解读中发现了许多陷阱。在本综述中,作者讨论了关于EGC-UH的ESD相关出版物解读中的陷阱。